GH Forecast



Bearish<—>Bullish



80% Confidence




Bullish Case: Guardant Health's strategic partnerships and increased testing volumes drive revenue growth and investor optimism, despite past price declines.




Bearish Case: High volatility and persistent skepticism from halted trials and legal issues weigh on Guardant Health's stock, despite growth opportunities.




Potential Outcomes: Continued revenue growth: 70%. Increased legal challenges: 40%. Market skepticism persists: 50%. Successful expansions boost price: 60%.




Trading Oracle: Adopt a bullish strategy with long-dated debit call spreads targeting $45-$50, expiring January 2026. With implied volatility backwardation, capitalize on upward bias and expected mean reversion for high reward:risk ratio.



February 22, 2025


Guardant Health Forecast

GH        Guardant Health











Correlated Assets

Assets that tend to move strongly with GH



HIMS Forecast + Options Trading Strategies   HIMS  Hims & Hers Health (0.84)


WIX Forecast + Options Trading Strategies   WIX  Wix.com (0.78)


HIMX Forecast + Options Trading Strategies   HIMX  Himax (0.75)


GLW Forecast + Options Trading Strategies   GLW  Corning (0.75)


JPM Forecast + Options Trading Strategies   JPM  JPMorgan Chase (0.75)



Uncorrelated Assets

Assets with little price relationship to GH



MAS Forecast + Options Trading Strategies   MAS  Masco (-0.0)


CAT Forecast + Options Trading Strategies   CAT  Caterpillar (-0.01)


CPS Forecast + Options Trading Strategies   CPS  Cooper-Standard (-0.02)


IRBT Forecast + Options Trading Strategies   IRBT  Irobot (0.03)


LDOS Forecast + Options Trading Strategies   LDOS  Leidos (0.04)



Anticorrelated Assets

Assets that tend to move strongly against GH



XP Forecast + Options Trading Strategies   XP  XP (-0.78)


BC Forecast + Options Trading Strategies   BC  Brunswick (-0.79)


HUN Forecast + Options Trading Strategies   HUN  Huntsman (-0.8)


ABEV Forecast + Options Trading Strategies   ABEV  Ambev (-0.8)


IOVA Forecast + Options Trading Strategies   IOVA  Iovance Biotherapeutics (-0.86)









Become a more profitable investor with AI optimized trading strategies






×

Chat with GH


 Ask any question about GH!